An open ended Equity scheme replicating MSCI India Domestic & World Healthcare 45 Index
Investment Objective : The Scheme will invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns. |
|
Inception Date | 26-Oct-2020 |
Benchmark | MSCI India Domestic & World Healthcare 45 Index |
Fund Managers Details | Mr. Bhavesh Jain Experience 16 years Managing Since 01-Oct-2021 Mr. Amit Vora (for investments in foreign securities) Experience 16 years Managing Since 12-Feb-2021 |
Minimum Investment Amount | Minimum of Rs. 100/-‐ and multiples of Re. 1/- thereafter. |
Additional investment amount | Minimum of Rs. 100/- and multiples of Re. 1/- thereafter. |
Plan/Options | Direct and Regular Plan with Growth and IDCW Reinvestment, Payout & Sweep |
Exit Load | NIL |
Total Expense Ratios~ | Regular 1.04% Direct 0.50% |
Tracking Error: | Regular: 0.83% |
Tracking error is annualised and is calculated based on data since inception. |
Month End AUM ` |
Rs. 152.76 Crore
|
Monthly Average AUM |
Rs. 154.48 Crore
|
Regular Plan - Growth |
19.0858
|
Regular Plan - IDCW |
19.0858
|
Direct Plan - Growth |
19.5602
|
Direct Plan - IDCW |
19.5602
|
(as on January 31, 2025) |
Name of Instrument
|
Industry
|
% to Net Assets
|
Equities | 99.71% | |
SUN PHARMACEUTICAL INDUSTRIES LTD | Healthcare | 12.37% |
MAX HEALTHCARE INSTITUTE LIMITED | Healthcare | 6.10% |
CIPLA LTD | Healthcare | 5.74% |
ELI LILLY & CO | Pharmaceuticals | 5.61% |
DR. REDDY'S LABORATORIES LTD | Healthcare | 5.26% |
APOLLO HOSPITALS ENTERPRISES LTD | Healthcare | 5.07% |
DIVI'S LABORATORIES LTD | Healthcare | 4.93% |
LUPIN LTD | Healthcare | 3.51% |
JOHNSON & JOHNSON | Pharmaceuticals | 3.13% |
ABBVIE INC | Biotechnology | 2.78% |
TORRENT PHARMACEUTICALS LTD | Healthcare | 2.45% |
NOVO-NORDISK A/S-SPONS ADR | Healthcare | 2.33% |
FORTIS HEALTHCARE LTD | Healthcare | 2.32% |
AUROBINDO PHARMA LTD | Healthcare | 2.26% |
MERCK & CO. INC. | Pharmaceuticals | 2.14% |
THERMO FISHER SCIENTIFIC INC | Healthcare | 1.95% |
ABBOTT LABORATRIES | Health Care Equipment | 1.90% |
MANKIND PHARMA LTD. | Healthcare | 1.80% |
ZYDUS LIFESCIENCES LTD | Healthcare | 1.80% |
NOVARTIS AG - SPONSORED ADR | Pharmaceuticals | 1.77% |
INTUITIVE SURGICAL INC | Healthcare | 1.74% |
ALKEM LABORATORIES LTD | Healthcare | 1.57% |
GLENMARK PHARMACEUTICALS LTD | Healthcare | 1.52% |
LAURUS LABS LIMITED | Healthcare | 1.51% |
IPCA LABORATORIES LTD | Healthcare | 1.49% |
AMGEN INC | Healthcare | 1.31% |
DANAHER CORP | Healthcare | 1.24% |
STRYKER CORP | Healthcare | 1.15% |
BIOCON LTD | Healthcare | 1.12% |
GILEAD SCIENCES INC - COM USD0.001 (CLP) | Biotechnology | 1.04% |
PIRAMAL PHARMA LTD | Healthcare | 1.04% |
VERTEX PHARMACEUTICAL - COM STK USD0.01 | Healthcare | 1.02% |
SYNGENE INTERNATIONAL LTD | Healthcare | 1.00% |
MEDTRONIC PLC | Healthcare | 1.00% |
J. B. CHEMICALS & PHARMA LTD | Healthcare | 0.91% |
AJANTA PHARMA LTD | Healthcare | 0.87% |
GLAND PHARMA LIMITED | Healthcare | 0.84% |
SUVEN PHARMACEUTICALS LTD | Healthcare | 0.79% |
GLOBAL HEALTH LTD. | Healthcare | 0.62% |
REGENERON PHARMACEUTICALS INC | Healthcare | 0.62% |
GLAXOSMITHKLINE PHARMACEUTICALS LTD | Healthcare | 0.62% |
BECTON DICKINSON AND CO | Healthcare | 0.61% |
AGILENT TECHNOLOGIES INC | Healthcare | 0.37% |
IQVIA HOLDINGS INC | Healthcare | 0.31% |
ILLUMINA INC | Healthcare | 0.18% |
Cash & Other Receivables | 0.12% | |
TREPS_RED_03.02.2025 | 0.12% | |
Grand Total | 100.00% |
Period
|
Scheme - Regular Plan |
Benchmark (MSCI India Domestic & World Healthcare 45 Index#) |
Additional Benchmark (Nifty 50 TR Index) |
|||
Returns* |
Value of Rs. 10000 Invested |
Returns* |
Value of Rs. 10000 Invested |
Returns* |
Value of Rs. 10000 Invested |
|
1 Year |
16.21% |
11,625 |
17.39% |
11,744 |
9.55% |
10,958 |
3 Years |
16.48% |
15,812 |
16.42% |
15,785 |
12.01% |
14,058 |
Since Inception - Regular Plan |
16.35% |
19,086 |
16.86% |
19,446 |
18.97% |
20,991 |
Past performance may or may not be sustained in future and
should not be used as a basis for comparison with other investments.
Notes:
1. The performance details provided herein are of Edelweiss MSCI India Domestic & World Healthcare
45 Index Fund. Since Inception
returns are calculated on Rs. 10/- invested at inception. In case the start/end date is non business
day, the NAV of previous day is used for
computation.
2.The scheme is currently managed by Bhavesh Jain (managing this fund from October 01, 2021) and Amit
Vora (managing this fund from
February 12, 2021) Click
here for name of the other schemes currently managed by the Fund Managers and relevant scheme
for performance.
For performance of Direct Plan please
click here
Disclaimer of MSCI: MSCI Inc. (“MSCI”), is the Index Service Provider. MSCI has been formed with the objective of providing a variety of indices and index related services and products for the capital market. MSCI India Domestic & World Healthcare 45 Index, the underlying index for the Scheme, has been licensed from MSCI. MSCI India Domestic & World Healthcare 45 Index, is a public Index. The index values are calculated by MSCI on daily basis and put up on the MSCI website https://www.msci.com/index country membership tool.
Disclaimer of NSE: It is to be distinctly understood that the permission given by NSE should not in any way be deemed or construed that the Scheme Information Document has been cleared or approved by NSE nor does it certify the correctness or completeness of any of the contents of the Scheme Information Document. The investors are advised to refer to the Scheme Information Document for the full text of the 'Disclaimer Clause of NSE'. The “Product” offered by “the issuer” is not sponsored, endorsed, sold or promoted by NSE (formerly known as India Index Services & Products Limited (IISL)). NSE does not make any representation or warranty, express or implied (including warranties of merchantability or fitness for particular purpose or use) and disclaims all liability to the owners of “the Product” or any member of the public regarding the advisability of investing in securities generally or in “the Product” linked to MSCI India Domestic & World Healthcare 45 Index or particularly in the ability of the MSCI India Domestic & World Healthcare 45 Index to track general stock market performance in India. Please read the full Disclaimers in relation to the MSCI India Domestic & World Healthcare 45 Index in the in the Scheme Information Document.
This Product is suitable for investors who are seeking*:
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Benchmark Riskometer: MSCI India Domestic
& World Healthcare 45 Index